CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer

Sae Byul Lee, Junetae Kim, Guiyun Sohn, Jisun Kim, Il Yong Chung, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Sei-Hyun Ahn, Jong Won Lee, Kyung Hae Jung

Cancer Research and Treatment. 2019;51(3):1073-1085. Published online 2018 November 1 DOI: https://doi.org/10.4143/crt.2018.357

A nomogram for predicting the Oncotype DX recurrence score in women with T1-3N0-1miM0 hormone receptor-positive, human epidermal growth factor-2 (HER2)-negative breast cancer

S. Lee

Annals of Oncology. 2016;27:vi53

Link1 Link2 Link3

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer

Sae Byul Lee, Junetae Kim, Guiyun Sohn, Jisun Kim, Il Yong Chung, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Sei-Hyun Ahn, Jong Won Lee, Kyung Hae Jung

Cancer Research and Treatment. 2019;51(3):1073-1085

Link1

Link2 Link3

Evaluation of Prognosis in Hormone Receptor–Positive/HER2-Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score

Jane Meisel, Chao Zhang, Cameron Neely, Pia Mendoza, Shuo You, Tatiana Han, Yuan Liu, Aysegul A. Sahin, Ruth O'Regan, Xiaoxian Li

Clinical Breast Cancer. 2018;18(5):347-352

Link1 Link2

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?

Monica Maria Yepes, Ada Pat Romilly, Fernando Collado-Mesa, Jose Miguel Net, Richard Kiszonas, Kristopher L. Arheart, Daniel Young, Stefan Glück

Breast Cancer Research and Treatment. 2014;148(1):117-123

Link1

Link2 Link3

Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC)

A. Lau, D. Miller, D. Davison, M. Rothney, P. Borgen

The Breast. 2017;32:S97

Link1 Link2

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

A. Gasol Cudos, S. Morales Murillo, M.J. Panades Siurana, F. Vilardell Villellas, C. Canosa Morales, J. Mele Olive, E. Iglesias Martinez, A. Salud Salvia

The Breast. 2017;32:S92-S93

Link1 Link2

Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come

Elizabeth A. Mittendorf, Tari A. King

Annals of Surgical Oncology. 2019;26(5):1173-1175

Link1 Link2

Link3

The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

Maoli Wang, Kejin Wu, Peng Zhang, Mingdi Zhang, Ang Ding, Hongliang Chen

Annals of Surgical Oncology. 2018;26(5):1227-1235

Link1

Link2 Link3

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients

A. Munir, S. Udyashankar, D. Thomas, G. Dazeley, A. Huws, G. Bertelli, Y. Shariah, S. Khawaja, S. Holt

European Journal of Surgical Oncology (EJSO). 2016;42(9):S103

Link1 Link2

Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer

Aline Baltres, Zeina Al Masry, Ryad Zemouri, Severine Valmary-Degano, Laurent Arnould, Noureddine Zerhouni, Christine Devalland

Breast Cancer. 2020;27(5):1007-1016

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.